Paclitaxel and docetaxel in the treatment of breast cancer

By Saloustros Emmanouel   Mavroudis Dimitris   Georgoulias Vassilis  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2603-2616

Informa Healthcare

Access to resources Recommend Favorite

Cancer treatment and pharmacogenetics of cytochrome P450 enzymes

By Schaik Ron  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 513-522

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics of folate-related drug targets in cancer treatment

By Robien Kim   Boynton Alanna   Ulrich Cornelia M  

Pharmacogenomics, Vol. 6, Iss. 7, 2005-10 ,pp. : 673-689

Future Medicine

Access to resources Recommend Favorite

Discordant somatic and germline VEGF-A genotype in a cancer patient resistant to paclitaxel/bevacizumab with chemosensitive hepatic metastasis

By Coltelli Luigi   Allegrini Giacomo   Orlandi Paola   Giuntini Nicola   Alìì Greta   Fioravanti Anna   Bona Eleonora   Barletta Maria Teresa   Fontanini Gabriella   Tacca Mario Del   Danesi Romano   Falcone Alfredo   Bocci Guido  

Pharmacogenomics, Vol. 10, Iss. 8, 2009-08 ,pp. : 1225-1229

Future Medicine

Access to resources Recommend Favorite

Paclitaxel: A Pharmacoeconomic Review of its Use in the Treatment of Ovarian Cancer

By Young M.   Plosker G.L.  

PharmacoEconomics, Vol. 19, Iss. 12, 2001-01 ,pp. : 1227-1259

Adis International

Access to resources Recommend Favorite